Lenz Therapeutics, Inc. <LENZ.O>: Leerink Partners cuts target price to $10 from $20
LENZ•Related News
New attacks on shipping as Iran war talks hit fresh impasse
XLE•
Forex-Dollar drifts as markets await US inflation data for Fed clues
TLT•
ANI Pharma SVP, Generics Ori Gutwerg reports sale of 3,162 common shares worth $243,474
ANIP•
Oil rises as doubts over US-Iran deal heighten supply concerns
XLE•
The Middleby Corporation <MIDD.O>: Canaccord Genuity cuts target price to $157 from $165
MIDD•